What if we could prevent #heartfailure deaths?
What if #therapies already exist?
What if the #cost was worth it?
In @JCardFail, we show the #costeffective promise of rapid GDMT titration from #STRONGHF
Quad therapy $47,000/QALY, Less for the Brits!
https://t.co/Q9QTnff0ic
Join us in Boston on Oct. 26 for a symposium to celebrate cost-effectiveness analysis. Hosted by @PeterNeumann11 and @GSchmidler, the event will feature panel discussions w/ CEA luminaries and celebrate 25th Anniversary of CEVR's CEA Registry.
Details at https://t.co/aCXKFVw4s9
Our study led by Dan and @tara_lavelle tried to tease out the public’s opinion on QALY, evLY, HYT, and other measures. Beyond this poster, I had a fun experience at @ISPORorg with my great @TuftsCEVR colleagues! #value#heor#atlanta
5.8 yrs – that's how much longer the avg American woman could expect to live vs the avg man in 2021
That's also the the widest gender gap in #lifeexpectancy since 1996.
Our study in @JAMAInternalMed investigates why.
A thread:
https://t.co/mzfS2SRtbh
Do health plans cite different types of evidence for drugs indicated for different diseases?
Analysis of the SPEC Database shows stark differences across diseases
Some highlights:
Cardiology: 63% Clinical guidelines
Respiratory: 39% RCTs
Ophthalmology: 19% RWE
💡Just wrapped up an incredible focus group meeting! Participants shared valuable insights on health gain measures. Stay tuned for the outcomes! #CMWF#healthgains#focusgroup
🚨 Calling all participants! Researchers at Tufts Medical Center are conducting an exciting research study and need your valuable input! If interested, click here to complete a short survey: https://t.co/2z4UBmUAo3
"This study shows that whole genome sequencing, while still imperfect, remains the gold standard for accurate diagnosis of genetic disorders in newborns and infants." -- Dr. Jonathan Davis on the GEMINI study findings: https://t.co/ViKOBYRRfn
#TuftsMedicine@NIH
Calling all participants! Researchers at Tufts Medical Center are conducting an exciting research study and need your valuable input! We are seeking individuals to represent patient, caregiver, clinician, pharmacist, allied health, and civil society perspectives.